PharmEasy still big drag on Prosus’ portfolio in H1

Online pharmacy startup PharmEasy has delivered an internal rate of return (IRR) of -38% for global investment firm Prosus in the first half of this fiscal, according to the firm’s half-yearly investor presentation. Meanwhile, B2B e-commerce platform ElasticRun recorded an IRR of 23%.

Besides these two, Swiggy and PayU India reported an IRR of 21% each, while Meesho had an IRR of 20%, and ed-tech startup Eruditus generated returns of 14%. However, Eruditus is the only company in Prosus’s ed-tech portfolio that has generated positive returns in H1.